Parthenon LLC Q4 2022 vs. Q1 2023: Insights on Fund Holdings Changes

As we move forward into a new year, it's always fascinating to reflect on the changes made by prominent companies and investors during the previous period. In this regard, we are presenting a report on Parthenon LLC Q4 2022 vs. Q1 2023 13F holdings comparison. The report provides an analysis of the holdings of Parthenon LLC, a private equity firm based in Boston, Massachusetts.

Parthenon LLC manages a diversified portfolio of companies across different sectors, including technology, healthcare, consumer retail, and industrials. The firm employs a value-oriented investment approach to achieve its long-term investment objectives.

In the Q4 2022 period, Parthenon LLC had total holdings with a value of $573,077, represented by 43 stocks. In the Q1 2023 period, Parthenon LLC increased its portfolio's size, translating to a total value of $657,221, with holdings in 47 stocks. The total value of holdings grew by 14.7% quarter-over-quarter.

Here are some of the key takeaways from the report, highlighting the significant changes made in the portfolio of Parthenon LLC:

Microsoft (MSFT)

Parthenon LLC maintained its ownership of Microsoft shares, with total holdings amounting to 279,951 shares in both quarters. In terms of value, the Q4 2022 figure was $67,237, increasing to $80,709, representing a percentage change of 20%.

Apple Inc (AAPL)

Apple Inc was a top performer for Parthenon LLC, as the firm increased its shares by 3,500, translating to a 2.7% change, from 130,131 shares in Q4 2022 to 128,491 in Q1 2023. The value of holdings in AAPL rose by 25.3%, from $16,907 to $21,188.

Meta Platforms Inc (META)

Parthenon LLC recorded an impressive 76.7% increase in its holding of Meta Platforms Inc (formerly Facebook) shares from 79,861 shares in Q4 2022 to 80,111 in Q1 2023. The value of holdings rose from $9,610 to $16,978 over the two quarters.

Johnson & Johnson (JNJ)

Parthenon LLC reduced its holdings in Johnson & Johnson by 260 shares, a 0.2% change, from 146,254 shares in Q4 2022 to 146,514 in Q1 2023. The value of holdings decreased by 12.1%, from $25,835 to $22,709, representing a below-average performance in the healthcare sector.

CVS Health Corp (CVS)

Parthenon LLC decreased its shareholding in CVS Health Corp by 3,725, translating to a 2.34% change from 159,328 shares in Q4 2022 to 163,053 in Q1 2023. The decrease led to a percentage change in the value of holdings, which dropped by 18.4%, from $14,847 to $12,116.

In conclusion, the report highlights a general trend of growth in Parthenon LLC's portfolio, with a significant increase in the total value of holdings between the quarters. The firm maintained its position in some top-performing technology companies such as Microsoft and Apple Inc, and also had an outstanding performance in companies such as Meta Platforms Inc.

On the other hand, the portfolio witnessed a decrease in holdings in companies such as Johnson & Johnson and CVS Health Corp. As always, investors are advised to carry out additional research before investing in any of the stocks highlighted in this report.